Hold rating: $760 target. Ad growth is strong, but AI capex and legal risks pressure FCF and buybacks. See more details here.

Australia’s seasonally adjusted unemployment rate held steady at 4.7% in September 2026, matching the upwardly revised August ...

Asian stock indices posted widespread losses on Thursday, following an overnight downturn on Wall Street driven by ...

Quantum computing has become a hot topic in the Bitcoin ecosystem. 'Q-Day' is the hypothetical date on which a ...

US midterm elections are adding another layer of risk to market sentiment amid a myriad of complications competing for ...

Orchestra BioMed (OBIO) stock is rated Hold at $5.72 ahead of pivotal hypertension pacemaker trial data (Q2 2027). See here ...

Mid-cap growth stocks returned roughly 18% in the second quarter of 2025, outperforming mid-cap value by 13 percentage points ...

If you look closely at a YTD chart of the price of crude, you will notice that the price topped out (at least for now) way ...

Current market expectations show a 63% chance of a hold at the next Fed meeting versus a 37% chance of a 25 basis point hike.

Anthropic (ANTHRO) reports $16.8B Q3 revenue (+45%) ahead of a November IPO, plus 85% margins and positive cash flow.

ByteDance ( BDNCE) is nearing an agreement to buy custom chips from MediaTek for its data centers, Bloomberg reported, citing ...

OMAH ETF review: 15% payout may erode NAV; high fees and options cap upside vs. Berkshire. Read here for a detailed analysis.